0
Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients With COVID-19 (BIRCH): A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study. (academic.oup.com)
Authors:
Streinu-Cercel A
… Gonzalez Del Castillo JM
Journal:
Clinical Infectious Diseases
Published:
2026-02-09
DOI:
https://doi.org/10.1093/cid/ciaf406
Comments
Login to comment.
No comments yet. Be the first!